SIGANasdaqPharmaceutical PreparationsFiscal year ends December 31

SIGA TECHNOLOGIES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$3.14−0.03 (-0.95%)

Close on Oct 19, 2026

Market cap: $225.72M
P/E (TTM): –
Dividend yield: 19.11%

SIGA TECHNOLOGIES INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	95	139	140	111	134	125	27	477	12	15	–	–	–	–	–	–	–
Cost of Revenue	30	31	18	10	17	15	1.78	95	0	0	–	–	–	–	–	–	–
Gross Profit	65	107	122	100	117	110	25	382	12	15	–	–	–	–	–	–	–
Research & Development	20	12	16	23	9.94	11	13	13	17	20	13	11	14	18	18	23	17
Selling, General & Admin	21	25	22	35	18	15	13	13	12	14	11	13	13	11	24	8.13	7.53
Operating Expenses	–	–	–	–	–	–	29	122	31	46	39	213	29	32	44	32	26
Total Costs & Expenses	71	69	56	68	45	40	29	122	–	–	–	–	–	–	–	–	–
Operating Income	24	70	84	43	89	85	-2.32	355	-19	-31	-31	-210	-24	-23	-31	-13	-12
Interest Expense	–	–	–	0	0	3.02	16	15	15	2.40	0.27	0.46	1.21	0.17	0	0	–
Other Non-Operating Income	6.68	6.09	4.16	1.03	0.10	0.53	2.82	79	0.02	0.10	0.04	0.00	0.00	0.00	0.01	0.66	0.00
Merger & Restructuring Charges	–	–	–	–	–	–	–	–	–	–	0	0	0.51	0	0	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	–	0	0	0.35	0	0	–	–	–
Pretax Income	30	76	88	44	89	74	-10	412	-38	-40	-39	-212	-25	-22	-6.93	-50	-19
Income Tax Expense	7.10	17	20	10	20	17	-2.94	-10	-2.09	0.01	0.46	54	-7.62	-7.84	-36	0.18	0
Net Income	23	59	68	34	69	56	-7.24	422	-36	-40	-39	-265	-17	-14	29	-50	-19
EPS (Basic)(per share)	0.33	0.83	0.95	0.46	0.92	0.71	-0.09	5.28	-0.46	-0.69	-0.73	-4.97	-0.33	-0.27	0.57	-1.12	-0.52
EPS (Diluted)(per share)	0.32	0.82	0.95	0.46	0.91	0.71	-0.15	5.18	-0.46	-0.69	-0.73	-4.97	-0.33	-0.27	0.09	-1.12	-0.52
Shares Outstanding (Basic, Weighted)(shares)	72	71	71	73	75	79	81	80	79	57	54	53	52	52	51	45	37
Shares Outstanding (Diluted, Weighted)(shares)	72	72	72	74	76	79	82	83	79	57	54	53	52	52	54	45	37
Dividend per Share(per share)	0.60	0.60	0.45	0.45	–	–	–	–	–	–	–	–	–	–	–	–	–
EBITDA	24	71	84	43	90	85	-1.80	355	-19	-31	-31	-209	-23	-22	-31	-12	-11

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 54.4%
Operating margin: -20.8%
Net margin: -5.2%
Return on equity, FY2025: 11.2%

Financial strength

Current ratio: 21.72
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 1498.8%

Valuation

P/E ratio: –
Price to sales: 4.21
Price to book: 1.37
Dividend yield: 19.11%